SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024
26 November 2024 - 2:00PM
SeaStar Medical Holding Corporation (Nasdaq: ICU), a
commercial-stage medical device company developing proprietary
solutions to reduce the consequences of hyperinflammation on vital
organs, announces that management will present a company overview
at NobleCon20, Noble Capital Markets’ 20th Annual Emerging Growth
Equity Conference, on Wednesday, December 4 at 12:00 p.m. Eastern
time (9:00 a.m. Pacific time). The conference is being held in Boca
Raton, Fla.
A webcast of the presentation will be available
beginning December 5 on the Company website and will be archived
for 90 days.
About SeaStar Medical
SeaStar Medical is a commercial-stage medical
technology company that is redefining how extracorporeal therapies
may reduce the consequences of excessive inflammation on vital
organs. SeaStar Medical’s novel technologies rely on science and
innovation to provide life-saving solutions to critically ill
patients. The Company is developing and commercializing
cell-directed extracorporeal therapies that target the effector
cells that drive systemic inflammation, causing direct tissue
damage and secreting a range of pro-inflammatory cytokines that
initiate and propagate imbalanced immune responses. For more
information visit www.seastarmedical.com or visit us on LinkedIn or
X.
Contact:
Alliance Advisors IRJody Cain(310)
691-7100Jcain@allianceadvisors.com
# # #
SeaStar Medical (NASDAQ:ICU)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
SeaStar Medical (NASDAQ:ICU)
Historical Stock Chart
Von Dez 2023 bis Dez 2024